Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Bone Marrow Transplantation
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
May 1997, Volume 19, Number 10, Pages 1049-1051
Table of contents    Previous  Abstract  Next   Article  PDF
Case report
Reversible brain MRI changes in acyclovir neurotoxicity
M E G Blohm1, W Nürnberger1, A Aulich2, V Engelbrecht2 and S Burdach1

1Department of Paediatric Haematology and Oncology, Heinrich Heine University Medical Centre, Düsseldorf, Germany,

2Department of Diagnostic Radiology, Heinrich Heine University Medical Centre, Düsseldorf, Germany

Abstract

This case report shows reversible brain MRI changes probably associated with acyclovir toxicity. So far, neuroimaging in acyclovir toxicity had been negative or uninformative. A 12-year-old girl developed focal secondary generalizing epileptic fits following 4 weeks of prophylactic administration of acyclovir (3 ´ 10 mg/kg body weight/day i.v.) on day +22 after allogeneic peripheral blood stem cell transplantation for CML. Infective causes were excluded. Brain MRI demonstrated multiple gadolinium-enhancing areas with impairment of the blood-brain barrier in cortical and subcortical regions. Clinical symptoms and neuroimaging pathology resolved completely within 9 days of acyclovir withdrawal.

Keywords

brain; gadolinium contrast; MRI; acyclovir; toxicity

Received 11 November 1996; accepted 3 February 1997
May 1997, Volume 19, Number 10, Pages 1049-1051
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1997 Nature Publishing Group